Superoxide Dismutase 1-Amyotropic Lateral Sclerosis

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Superoxide Dismutase 1-Amyotropic Lateral Sclerosis trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

APPROVED_FOR_MARKETINGNot Applicable

NCT04972487

Expanded Access Program for Tofersen in Participants With Superoxide Dismutase 1-Amyotropic Lateral Sclerosis

The objective of this early access program (EAP) is to provide access to tofersen to eligible participants with amyotrophic lateral sclerosis (ALS) associated w…

United States

Treatment: Tofersen